Rice Hall James & Associates’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-60,606
| Closed | -$4.96M | – | 269 |
|
|
2022
Q3 | $4.96M | Sell |
60,606
-27,116
| -31% | -$2.22M | 0.29% | 84 |
|
|
2022
Q2 | $5.93M | Sell |
87,722
-1,940
| -2% | -$131K | 0.29% | 75 |
|
|
2022
Q1 | $9.91M | Buy |
89,662
+4,553
| +5% | +$503K | 0.4% | 68 |
|
|
2021
Q4 | $8.21M | Sell |
85,109
-8,348
| -9% | -$805K | 0.29% | 73 |
|
|
2021
Q3 | $8.16M | Sell |
93,457
-503
| -0.5% | -$43.9K | 0.3% | 73 |
|
|
2021
Q2 | $14.5M | Sell |
93,960
-10,243
| -10% | -$1.59M | 0.52% | 59 |
|
|
2021
Q1 | $16.4M | Buy |
104,203
+703
| +0.7% | +$111K | 0.54% | 53 |
|
|
2020
Q4 | $24M | Buy |
103,500
+6,485
| +7% | +$1.51M | 0.85% | 39 |
|
|
2020
Q3 | $21.2M | Buy |
97,015
+46,227
| +91% | +$10.1M | 0.86% | 35 |
|
|
2020
Q2 | $14.4M | Buy |
50,788
+11,005
| +28% | +$3.13M | 0.62% | 50 |
|
|
2020
Q1 | $11.5M | Buy |
+39,783
| New | +$11.5M | 0.64% | 47 |
|